{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:06:13Z","timestamp":1790917573847,"version":"4.1.0"},"reference-count":20,"publisher":"BMJ","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"published-print":{"date-parts":[[1992,1]]},"abstract":"<jats:p>AIMS: Serum concentrations of tumour necrosis factor-alpha (TNF) were determined in beta thalassemic patients before and after bone marrow transplantation (BMT) to evaluate whether changes in TNF concentrations after BMT were related to immune mediated complications. METHODS: Serum TNF concentrations were determined by enzyme linked immunoassay (EIA) in paired samples from 71 patients with beta thalassemia before and after BMT. Serial samples from 13 patients were also studied for up to six months after BMT. Forty one normal healthy children matched for sex and age were studied as controls. RESULTS: beta thalassemic patients had high serum TNF concentrations before transplantation compared with controls. These were not related to sex, age, duration of disease, number of blood transfusions, transferrin concentrations or splenectomy. DQw1 positive patients showed significantly lower TNF concentrations than non-DQw1 cases. Patients with severe liver fibrosis had significantly higher TNF concentrations. No correlation was found between TNF values and BMT outcome before transplantation but TNF alpha values fell significantly after BMT. The decrease persisted only in patients with successful engraftment. In serial samples studied for up to six months after BMT, TNF values decreased but in four out of five patients with graft rejection and in all five with acute graft versus host disease (GVHD) sharp increases occurred at the time of clinical symptoms. No correlation was found between the degree of GVHD and serum TNF-alpha concentrations nor between TNF-alpha concentrations after BMT and the presence of bacterial, viral, and fungal infections. CONCLUSIONS: About 50% of beta thalassemic patients have increased serum TNF, and the changes after BMT are related to the occurrence of immune mediate complications. The persistence of low TNF concentrations after successful engraftment may be due to the preparative regimen and the lack of adverse immune reactions.<\/jats:p>","DOI":"10.1136\/jcp.45.1.61","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T00:50:46Z","timestamp":1181350246000},"page":"61-65","source":"Crossref","is-referenced-by-count":11,"title":["Increased serum concentrations of tumour necrosis factor in beta thalassaemia: effect of bone marrow transplantation."],"prefix":"10.1136","volume":"45","author":[{"given":"R","family":"Meliconi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Uguccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Lalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nesci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Delfini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Paradisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Lucarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Facchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1992,1,1]]},"reference":[{"key":"ref_1","article-title":"Inductionof human'ine-ukin I mRNAAmeauredby o D eand prr eagladin E2-stimulatingactivityin re d synovial cell","author":"DayerJM, Zavad; GrobbC, UdaC; MachB","year":"1984","unstructured":"DayerJM, Zavad,-GrobbC,UdaC, MachB. Inductionof human'ine-ukin I mRNAAmeauredby o D eand prr eagladin E2-stimulatingactivityin re d synovial cell. Ear J Ix _nol 1984;14.898-901.","journal-title":"Ear J Ix _nol"},{"key":"ref_2","first-page":"665","article-title":"Characterzat of receptor for human tumor necrosis fictor and their reulnbyg -i nro","volume":"318","author":"Agganwl, B.B.; Eesalu, T.E.; Has, P.B.","year":"1985","unstructured":"Agganwl BB, Eesalu TE, Has PB. Characterzat of receptor for human tumor necrosis fictor and their reulnbyg -i nro Nanawe 1985;318:665-8.","journal-title":"Nanawe"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7626","DOI":"10.1073\/pnas.82.22.7626","article-title":"Tumor necosis factor: specific binding d i alzation sensitive and resistant cls","volume":"82","author":"Tsujimoto, M.; Yip, Y.K.; Vilcek, J.","year":"1985","unstructured":"Tsujimoto M, Yip YK, Vilcek J. Tumor necosis factor: specific binding d i alzation sensitive and resistant cls. PrOc Nad cad Sci USA 1985;82:7626-31.","journal-title":"PrOc Nad cad Sci USA"},{"key":"ref_4","first-page":"511","article-title":"Immune status inmd_isaemiamsjor","volume":"71","author":"Nri, A.; Calles, V.; D'Aswc, D.G.; Martin, B.","year":"1986","unstructured":"Nri A, Calles V, D'Aswc DG, Martin B. Immune status inmd_isaemiamsjor. Haao l 1986;71:511-6."},{"key":"ref_5","first-page":"1355","article-title":"a al. Marrow at for b snw ifo own ing and cycloplaipluide Lca","volume":"8442","author":"Lucareli, G.; PNili, P.; ei M, G.","year":"1985","unstructured":"Lucareli G, PNili P, G ei M,a al. Marrow at for b snw ifo own ing and cycloplaipluide Lca 1985;i(8442):1355-7."},{"key":"ref_6","first-page":"3161050","article-title":"Marrow trans- _*deinpaiasxswihadvoncedhaasia","author":"Lucarefli, G.; rti h, Galim; Pbk, i P.","year":"1987","unstructured":"Lucarefli G, Galim rti h, Pbk:i P, et al. Marrow trans- _*deinpaiasxswihadvoncedhaasia.NEwglJ Mad 1987;3161050-5.","journal-title":"NEwglJ Mad"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00007890-197103000-00004","article-title":"A i mixed eukocyte TNF in, B thalassaemia: culture test","volume":"11","author":"Sengr, D.P.S.; Temki, P.I.","year":"1971","unstructured":"Sengr DPS, Temki PI. A i mixed eukocyte TNF in,B thalassaemia: culture test. Transplantation 1971;11:260-7.","journal-title":"Transplantation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJM197504242921706","article-title":"Bone-marrow transplantation (second of two parts)","volume":"292","author":"Thomas, E.D.; Storb, R.; Clift, R.A.","year":"1975","unstructured":"Thomas ED, Storb R, Clift RA, et al. Bone-marrow transplantation (second of two parts). N Engi J Med 1975;292:895-02.","journal-title":"N Engi J Med"},{"key":"ref_9","first-page":"1233","article-title":"Heritable major histocompatibility complex class II-associated differences in production oftumor necrosis factor: Relevance to genetic predisposition to","volume-title":"systemic lupus erythematosus. Proc Nati Acad Sci","volume":"87","author":"Jacob, C.O.; Fronek, Z.; Lewis, G.D.; Koo, M.; Hansen, J.A.; McDevitt, H.O.","year":"1990","unstructured":"Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production oftumor necrosis factor: Relevance to genetic predisposition to systemic lupus erythematosus. Proc Nati Acad Sci USA 1990;87:1233-7."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0140-6736(86)92007-6","article-title":"Raised serum levels of tumour necrosis factor in parasitic infections","volume":"ii:","author":"Scuderi, P.; Sterling, K.E.; Lam, K.S.","year":"1986","unstructured":"Scuderi P, Sterling KE, Lam KS, et al. Raised serum levels of tumour necrosis factor in parasitic infections. Lancet 1986;ii:1364-5.","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/0140-6736(90)92482-W","article-title":"Tumour-necrosis factor in normal plasma","volume":"336","author":"McLaughlin, P.J.; Davies, H.M.; Aikawa, A.","year":"1990","unstructured":"McLaughlin PJ, Davies HM, Aikawa A. Tumour-necrosis factor in normal plasma. Lancet 1990;336:1014-5.","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-3083.1989.tb01204.x","article-title":"Auto-antibodies to tumour nerosis factor a in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections","volume":"30","author":"Fomsgaard, A.; Svenson, M.; Bendtzen, K.","year":"1989","unstructured":"Fomsgaard A, Svenson M, Bendtzen K. Auto-antibodies to tumour nerosis factor a in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections. Scand J Immunol 1989;30:219-23.","journal-title":"Scand J Immunol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1172\/JCI114853","article-title":"Characterization in vitro ofa human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor","volume":"86","author":"Lantz, M.; Gullberg, U.; Nilsson, E.; Olsson, I.","year":"1990","unstructured":"Lantz M, Gullberg U, Nilsson E, Olsson I. Characterization in vitro ofa human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. J Clin Invest 1990;86:1396-402.","journal-title":"J Clin Invest"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1084\/jem.172.2.599","article-title":"Shedding of tumor necrosis factor receptors by activated human neutrophils","volume":"172","author":"Porteu, F.; Nathan, C.","year":"1990","unstructured":"Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 1990;172:599-607.","journal-title":"J Exp Med"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.3933111","article-title":"Recombinant human tumor necrosis factor: effects of proliferation of normal and transformed cells in vitro","volume":"230","author":"Sugarmann, B.J.; Aggarawal, B.B.; Figari, I.S.; Palladino, M.A.","year":"1985","unstructured":"Sugarmann BJ, Aggarawal BB, Figari IS, Palladino MA. Recombinant human tumor necrosis factor: effects of proliferation of normal and transformed cells in vitro. Science 1985;230:943-7.","journal-title":"Science"},{"key":"ref_16","first-page":"122","article-title":"Cachectin\/tumor necrosis factor","volume":"1","author":"Tracey, K.J.; Vlassara, H.; Cerami, A.","year":"1989","unstructured":"Tracey KJ, Vlassara H, Cerami A. Cachectin\/tumor necrosis factor. Lancet 1989;i:1 122-6.","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.170.3.655","article-title":"Tumor necrosis factor\/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis","volume":"170","author":"Piguet, P.F.; Collart, M.A.; Grau, G.E.; Kapanci, Y.; Vassalli, P.","year":"1989","unstructured":"Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P. Tumor necrosis factor\/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. JExp Med 1989;170:655-63.","journal-title":"JExp Med"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1182\/blood.V75.4.1011.1011","article-title":"Increased serum levels of tumor necrosis factor precede major complications ofbone marrow transplantation","volume":"75","author":"Holler, E.; Kolb, H.J.; Moller, A.","year":"1990","unstructured":"Holler E, Kolb HJ, Moller A, et al. Increased serum levels of tumor necrosis factor precede major complications ofbone marrow transplantation. Blood 1990;75:1011-6.","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-1759(89)90198-1","article-title":"Specific assays for cytokine production by T cells","volume":"116","author":"Mosmann, T.R.; Fong, T.A.T.","year":"1989","unstructured":"Mosmann TR, Fong TAT. Specific assays for cytokine production by T cells. J Immunol Methods 1989;116: 151-8.","journal-title":"J Immunol Methods"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM199103073241005","article-title":"Graft-versus-host disease","volume":"324","author":"Ferrara, J.L.M.; Deeg, H.J.","year":"1991","unstructured":"Ferrara JLM, Deeg HJ. Graft-versus-host disease. N Engi J Med 1991;324:667-74.","journal-title":"N Engi J Med"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.45.1.61","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:16:44Z","timestamp":1758817004000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.45.1.61"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,1]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1992,1,1]]},"published-print":{"date-parts":[[1992,1]]}},"alternative-id":["10.1136\/jcp.45.1.61"],"URL":"https:\/\/doi.org\/10.1136\/jcp.45.1.61","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,1]]}}}